Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.
Posts by this author
Quartic.ai and Bright Path Labs Partner to Deliver AI Powered Continuous Manufacturing of Critical APIs for Life-Saving Medicines
SAN JOSE, Calif. (May 6, 2020 ) - Quartic.ai, a manufacturing AI and IIoT platform supplier, and Bright Path Laboratories, Inc. (Bright Path Labs), a provider of continuous flow reactor technologies, signed an agreement to develop an AI powered continuous manufacturing platform for active pharmaceutical ingredients (APIs) and other small molecule drugs using Bright Path Labs’ continuous bioreactor and the Quartic.ai smart manufacturing technology.
